Download Adverse effects of antimuscarinic drugs

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Orphan drug wikipedia , lookup

Drug discovery wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Discovery and development of beta-blockers wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Discovery and development of proton pump inhibitors wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Bad Pharma wikipedia , lookup

Stimulant wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Prescription drug prices in the United States wikipedia , lookup

Pharmacognosy wikipedia , lookup

Medication wikipedia , lookup

Theralizumab wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Prescription costs wikipedia , lookup

Neuropharmacology wikipedia , lookup

Drug interaction wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Bilastine wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
Anticholinergic Drugs
In contrast to cholinergic agonists which have limited usefulness therapeutically, the
cholinergic blockers are beneficial in a variety of clinical situations
Antimuscarinic Agents:
1- M1 Selective.
2- Non selective.
Tertiary amine
1- Atropine prototype. 2- Hemoatropine 3- Scopolamin
quaternary amine
produce more peripheral effects with decrease CNS effect.
Include: Propantheline , Ipratropium , Clidinium bromide.
They are absorbed from GIT, mucus membrane , skin and eye .
Scopolamine has greater effect on CNS & eye than atropine.
- Atropine has greater effect on heart, intestine, bronchi and urinary tissue than
scopolamine
Atropine has a high affinity for muscarinic receptors, where it binds competitively &
reversiblely,preventing Ach from binding to that site.
Atropine is both a central and peripheral muscarinic blocker.
Atropine opposes the effects of all cholinergic drug
Actions of Atropine
1- CNS:
minimal stimulant effect and slow sedation.
2- On eye
a- Mydriasis (dilated pupil) b- Cycloplegia: By weakening the contraction
of ciliary muscle , so causing loss of ability to accommodate for near
vision c- Reduction of lachrymal secretion, causing dry or sandy eyes.
d- Increase intraocular pressure
block the cardiac receptors on the SA node to vagus nerve so the cardiac
rate increases modestly (tachycardia). with poisoning, there is marked
vasodilatation.
bronchial dilatation , decrease secretion
3- On CVS
4- On
Respiratory
5Gastrointestinal
(GlT):
6-genito-urinary
tract
7- Exocrine
glands secretions
a- Antispasmodic due to reduction of GIT motility.
b- Block salivary glands secretion
smooth muscles of ureter and bladder wall are relaxed and urination is
slowed
All decrease (exceptMilk) dry mouth, dry eyes, dry skin (inhibit
sweating), bronchial secretion decrease & become viscid.
Poisoning with Atropine
Features:
- Dry mouth with dysphasia.
- Mydriasis, blurred vision.
- Hot flushes , dry skin with hyperthermia (CNS effect - absence of sweating).
- Restlessness ,anxiety, excitement hallucinations, delirium, mania.
- The cerebral excitation is followed by depression and coma.
Treatment:
- By giving activated charcoal to adsorb the drug.
- Diazepam is given for excitement.
Clinical uses of antimuscarinic drugs
1. On CNS:
a- Benzhexol , against rigidity and tremor in parkinsonism.
b- Hyoscine,: used as antiemetic. And prevent or reduce motion sickness.
2. Ophthalmologic disorders:
used in cases that need mydriasis with cycloplagia or prolonged action .
-Tropicamide is the short acting mydriatic drug.
3. Respiratory disorder :
a. Preoperative: To decrease bronchial secretion & spasm
b- Ipratropium is useful in the treatment of asthma and COAD in patients unable to take
adrenergic agonists.
4. CVS disorders:
a. Myocardial infarction (MI) because it block reflex vagal stimulation (bradycardia)
accompany pain of inferior MI .
b. Atropine used to treat sinus bradycardia
5. GIT disturbances:
a. Propantheline (Duspataline): used as antispasmodic
Hyosine butyl bromide (Buscopan): effective relaxant of the
sm.m .
b- Peptic ulcer : M1 inhibitor (Pirenzepine).
c- In preanesthesia: they reduce salivation and gastric secretion.
d. Clidinium bromide: used in treatment of gastric disorders.
6. Urinary disorder
- Flavoxate, propantheline and oxybutynin, are used to relieve m-spasm
7. Atropine used as antidotes to cholinergic and anticholinesterase agent, it is drug of choice
to treat poisoning from organophosphate pesticides.
- Its also used to block muscarinic effects due to cholinergic drugs such a neostigmine are
used.
Adverse effects of antimuscarinic drugs
In the infants even ordinary dose could result in antimuscarinic fever, while in adults it
depends on the dose :
1. Small dose: decrease salivation , decreased bronchial secretion, decrease sweating .
2. medium dose: pupil dilation visual accommodation decreased and heart rate is increased .
3. Largest dose: inhibition to the urination and intestinal motility and this is followed by
decrease in gastric section and motility .
4. over dose: all above are exaggerated , with CNS excitation , restlessness , irritability and
hallucination.
II- Antinicotinic Agents:
1- Ganglionic Blocking Agents.
2- Neuromuscular Blocking Agents.
1- Ganglionic Blocking Agents
Hexamethionin, mecamylamine and other ganglion-blockers were mainly used in the
treatment of hypertension.
, the adverse effect of ganglion blocked are so severe (both sympathetic and
parasympathetic divisions are blocked), so that patients are unable to tolerate long term
treatment with them
Trimethaphan
It is the only Ganglion-blocker still in clinical use
It is used IV to treat severe accelerated hypertension (malignant hypertension).
these drugs cause postural hypotension.
2- Neuromuscular Blocking drug
These drugs are important for producing complete sk-m relaxation in surgery, by specific
blockade of the N-M
also relax the vocal cords and allow the passage of a tracheal tube.
- Patients who have received a M-relaxant should always have their respiration assisted or
controlled until the drug have been inactivated or antagonized.
Non Depolarizing Competitive
N-M blocking agents
Drugs of this group cause N-M block by competing with Ach at the receptor site at the N-M
junction so prevent depolarization of muscle cell membrane
Tubocurarine
- Is the prototype it produces a competitive block at the at the motor endplate of the muscle
causing flaccid paralysis lasts 30-60 min.
- Tubocurarine blocks autonomic ganglia and causes an initial transient drop in blood
pressure & cause histamine release which may induce bronchospasm.
The action of competitive N-M blocking drugs is antagonized by anticholinesterases, like
Neostigmine which preceded by atropine to prevent the parasympathetic autonomic effect
of Neostigmine (such as bradycardia and salivation)
Depolarizing Non competitive
N-M blocking agents
Suxamethonium (Succinylcholine)
- It attaches to the nicotinic receptors and acts like Ach to depolarize the N-M junction.
. Initially this produces short-lasting muscle fasciculation, followed within a few minutes by
muscle paralysis.
does not produce a ganglionic block, except in high doses, although it does have weak
histamine-releasing action
duration of action of succinylcholine is extremely short so used during anesthesia for brief
procedures
the succinylcholine action cannot be reversed by other drug
undergo rapid hydrolysis by plasma pseudo cholinesterase enzyme
its persistence in the body is increased by
1- Neostigmine, which inactivate that enzyme.
2- In patient with hepatic disease or severe malnutrition, whose plasma concentration of
enzyme may be lower than normal.
3- Procaine also is destroyed by this enzyme and so by competing with suxamethonium for
the enzyme, may prolong its action.
4- There are persons with hereditary defects in amount or kind of enzyme, who cannot
destroy the drug as rapidly as normal
Adverse effects of Succinylcholine
1- Hyperthermia
2- Apnea: A genetically related deficiency of plasma pseudo cholinesterase enzyme can lead
to apnea due to paralysis of the diaphragm
3- Cardiovascular
a- Repeated injections of suxamethonium can cause bradycardia and even cardiac arrest
b-It causes release of K from muscle which can be enough to cause cardiac arrest in patients
with already hyperthermia
4- Muscle pain lasting 1-3 days due to muscle fasciculation preceded the paralysis by
Suxamethonium.
5- High dose can stimulate the uterus
Contraindication of succinylcholine
1- Hypersensitivity to suxamethonium.
2- Severe liver disease
3- Burned patient
4- Pregnancy
Uses of N-M blocking agents
- The main use of these drugs is the producing complete skeletal muscle relaxation in
surgery.
Other uses:
1- Control Ventilation:
- In respiratory failure due to obstructive airway disease.
2- Treatment of convulsion:
- By decrease peripheral manifestation of convulsion
Myasthenia Gravis
It is a disease affecting neuromuscular junctions of skeletal muscle.
special autoimmune antibodies (Abs), which either block or causes lyses of the Ach
receptors.
- Cholinoceptors exist for about 7days in normal individuals but for only 1day in MG patient.
The characteristic symptoms of weakness and fatigability that decrease with rest and
worsen with exercise
Severe disease may affect all the muscles, including muscles necessary for respiration.
Edrophonium is used as a diagnostic test for MG.
2 mg dose is injected IV after baseline measurements of muscle strength have been
obtained. If no response occurs after 45 seconds, an additional 8 mg may be injected.
- If the patient has MG an improvement in the strength of muscles last for 15 minutes ( this
differentiate MG from cholinergic crisis due to excessive drug therapy in which there will be
worsening of the condition)
Treatment of myasthenia gravis
1- Chronic long-term therapy of MG is usually accomplished with neostigmine,
pyridostigmine.
The doses are titrated to optimum levels based on changes in muscle strength
If muscarinic effects of such therapy are prominent, they can be treated by atropine
(antimuscarinic drugs)
Longer-acting cholinesterase inhibitors such as the organophosphorous agents are not
used. ?? because ther are very long acting agent
2- Thymectomy
3- Adreno corticosteroid, (prednisolone), induce improvement in 80% of cases.
4- Immunosuppressive therapy . Aim is to eliminate Ach. Receptor auto-antibody.
Clinical indications of the cholinergic drugs (agonists)
1. Reduce IOP in patients with glaucoma and during ocular surgery.
2. Treatment of atony of (GIT & bladder).
3. Diagnose & treatment of myasthenia gravis.
4. Minor uses: as antidotes to:
a- Neuromuscular blocking agents (muscle relaxants), tubocurarine.
b- Drugs with anticholinergic effects such as tricyclic antidepressant, belladonna alkaloid.
Tacrine: The newest anticholinesterase agent used for treatment of mild to moderate
dementia associated with Alzheimer's disease
Adverse Reactions of all the cholinergic drugs
1. On eye
blurred vision , decrease accommodation and meiosis.
2. On skin
Increase sweating .
3. On GIT
Increase salivation , belching , nausea , vomiting , intestinal cramps
(abdominal colic) and diarrhea .
4. On CVS :
vasodilatation , decrease heart rate
5. At motor end hyperpolarization of the skeletal muscle which will reduce contraction .
plate
6. On CNS
irritability , anxiety and fear , some of them causes seizures.